July 31 (Reuters) - Specialty healthcare company Endo International Plc reported a better-than-expected quarterly profit, helped by a 60 percent rise in U.S. generic sales, and it raised its full-year forecast.
The company’s adjusted net income rose to $173.7 million, or $1.06 per share, in the second quarter ended June 30, from $166.3 million, or $1.42 per share, a year earlier.
Revenue rose about 1 percent to $718.7 million.
Analysts on average had expected earnings of 89 cents per share, on revenue of about $647 million, according to Thomson Reuters I/B/E/S. (Reporting by Natalie Grover in Bangalore; Editing by Maju Samuel)